Marina Pontello Cristelli
Overview
Explore the profile of Marina Pontello Cristelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bessa A, Cristelli M, Felipe C, Foresto R, Fonseca M, Pestana J, et al.
J Bras Nefrol
. 2025 Jan;
47(1):e20240060.
PMID: 39776149
Background: A new induction therapy strategy of a single 3 mg/kg dose of rabbit antithymocyte globulin (r-ATG) showed a lower incidence of acute rejection. Methods: The objective of this study...
2.
Foresto R, Souza R, Dos Anjos G, Nakamura M, Goulart H, Sampaio R, et al.
Vaccines (Basel)
. 2024 Oct;
12(10).
PMID: 39460302
The effect of initial immunosuppressive therapy on the kinetics of the SARS-CoV-2 vaccine-induced humoral response is unknown. Here, we compared the kinetics of SARS-CoV-2 vaccine-induced humoral response in chronic kidney...
3.
Mansur J, Chang-Davila D, Simoes M, Cristelli M, Stopa Martins S, Machado de Sousa Proenca H, et al.
Transplant Direct
. 2024 May;
10(6):e1651.
PMID: 38817628
Background: There is no consensus on the ideal strategy to treat posttransplant focal segmental glomerulosclerosis. The multiple-target therapy, which consisted of high-dose intravenous cyclosporine, prednisone, and plasmapheresis, showed favorable results....
4.
Custodio L, Stopa Martins S, Viana L, Cristelli M, Requiao-Moura L, Chow C, et al.
Pediatr Transplant
. 2024 Mar;
28(3):e14713.
PMID: 38553819
Background: This study aimed to compare the efficacy and safety of basiliximab (BAS) versus a single dose of anti-thymocyte globulin (r-ATG) induction therapy in pediatric kidney transplant recipients (KTRs). Methods:...
5.
Alfaro Villanueva L, Junior R, Rangel E, Modelli L, Viana L, Cristelli M, et al.
Clin Transplant
. 2024 Mar;
38(4):e15298.
PMID: 38545918
Background: Graft loss increases the risk of patient death after simultaneous pancreas-kidney (SPK) transplantation. The relative risk of each graft failure is complex due to the influence of several competing...
6.
Pestana J, Cristelli M, Tedesco Silva Jr H
Transplantation
. 2024 Mar;
108(4):813-818.
PMID: 38526427
No abstract available.
7.
Cristelli M, Fortaleza C, Pereira J, Taddeo J, Viana L, Requiao-Moura L, et al.
Transpl Infect Dis
. 2023 Nov;
26(1):e14204.
PMID: 38010722
Background: Because COVID-19 has been associated with high lethality rates among kidney transplant recipients (KTR), but also with a severe disruption and delays in overall healthcare, this study aims to...
8.
Amorim C, Cazetta G, Cristelli M, Requiao-Moura L, da Silva E, Pinheiro Vale L, et al.
Transplantation
. 2023 Nov;
108(4):963-969.
PMID: 37953468
Background: Omicron variant has been associated with milder cases of COVID-19 among kidney transplant recipients. However, little is known about postacute sequelae, referred to as Long COVID. Methods: Prospective, single-center...
9.
Fazio M, Cristelli M, Tomimori J, Koga C, Ogawa M, Beneventi G, et al.
J Bras Nefrol
. 2023 Aug;
45(4):480-487.
PMID: 37565728
Introduction: Previous research demonstrated benefits of late conversion to mTOR inhibitors against cutaneous squamous cell carcinomas (cSCC) in kidney transplant recipients (KTR), despite of poor tolerability. This study investigated whether...
10.
Toniato de Rezende Freschi J, Cristelli M, Viana L, Ficher K, Nakamura M, Proenca H, et al.
Transplantation
. 2023 Aug;
108(1):261-275.
PMID: 37525373
Background: Mammalian target of rapamycin inhibitors (mTORi), sirolimus (SRL) and everolimus (EVR), have distinct pharmacokinetic/pharmacodynamics properties. There are no studies comparing the efficacy and safety of de novo use of...